MAX HEALTHCARE INS Latest Share Price (MAXHEALTH)
TODAY IN ONE LINE
MAXHEALTH rose 1.2% on average volume, in line with Nifty's 0.3% move, supported by recent strong earnings.
With a market cap of ₹1.03 L Cr., it trades at a P/E of 70.43. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
MAX HEALTHCARE INS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 202.2% and Profit up 92.7%
- ●Healthy Operating MarginsOPM is structurally strong at 33.5%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.09x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 8.0%
- ●Expensive ValuationTrading at a high P/E ratio of 77.0x
- ●FII SellingFII holding decreased by 3.61% QoQ
- ●Rising Receivables vs SalesReceivables grew 51.0% outpacing sales growth of 30.0%
Latest MAX HEALTHCARE INS News
What changed recently?
Recent events, corporate actions, and announcements.
MAX HEALTHCARE INS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for MAX HEALTHCARE INS, framed against the sector median so the premium or discount is obvious at a glance.
MAX HEALTHCARE INS trades at a P/E of 70.43× and P/B of 9.55×, against the Healthcare sector median P/E of 45.85×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
MAX HEALTHCARE INS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for MAX HEALTHCARE INS — derived from the latest tape, not yesterday's close.
MAX HEALTHCARE INS last traded at ₹1,049.3 with an intraday range of ₹1,034.9–₹1,059.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1049.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1111.17 | +61.87 | +5.90% |
| R3 | 1086.17 | +36.87 | +3.51% |
| R2 | 1073.03 | +23.73 | +2.26% |
| R1 | 1061.17 | +11.87 | +1.13% |
| PIVOT | 1048.03 | -1.27 | -0.12% |
| CURRENT | 1049.30 | — | — |
| S1 | 1036.17 | -13.13 | -1.25% |
| S2 | 1023.03 | -26.27 | -2.50% |
| S3 | 1011.17 | -38.13 | -3.63% |
| S4 | 986.17 | -63.13 | -6.02% |
MAXHEALTH is trading Above CPR, indicating Bullishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹1034.9–₹1051.9
Trading Above opening range, showing Bullishness
MAX HEALTHCARE INS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for MAX HEALTHCARE INS — consolidated or standalone — with margins, YoY growth and key ratios inline.
MAX HEALTHCARE INS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1.03 L Cr. and reported EPS of ₹3.32.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 7,028 | 8,373 ▲ 19.1% |
| Sales Growth YoY %Derived | 30.01% | 19.14% |
| Other Income | 156 | 163 ▲ 4.5% |
| Total Income | 7,184 | 8,536 ▲ 18.8% |
| 1,477 | 1,790 ▲ 21.2% | |
| Gross ProfitDerived | 5,551 | 6,583 ▲ 18.6% |
| Gross Margin %Derived | 78.98% | 78.62% |
| 3,703 | 4,341 ▲ 17.2% | |
| EBITDA (Operating Profit)Derived | 1,849 | 2,243 ▲ 21.3% |
| OPM %Derived | 26.30% | 26.79% |
| 451 | 633 ▲ 40.5% | |
| Profit Before Tax (PBT) | 1,406 | 1,676 ▲ 19.1% |
| 330 | 233 ▼ 29.4% | |
| Effective Tax %Derived | 23.50% | 13.92% |
| Total Profit for Period | 1,076 | 1,442 ▲ 34.1% |
| Net Profit (Owner's PAT)Derived | 1,076 | 1,442 ▲ 34.1% |
| Net Profit Margin %Derived | 15.31% | 17.23% |
| PAT Growth YoY %Derived | 1.72% | 34.07% |
| Earnings Per Share (EPS ₹) | 11.07 | 14.82 ▲ 33.9% |
| Diluted Shares Outstanding (Cr) | 97 | 97 ▲ 0.1% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | -5 | -2 ▲ 65.3% |
| Total Expenses (incl. D&A & Interest) | 5,778 | 6,860 ▲ 18.7% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 16.70% | 16.21% |
| Other Cost % of RevenueDerived | 35.98% | 35.63% |
| Interest Coverage (x)Derived | 9.03x | 7.64x |
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,505 | 3,931 ▲ 57.0% | 4,563 ▲ 16.1% | 5,406 ▲ 18.5% | 7,028 ▲ 30.0% | 8,373 ▲ 19.1% | |
| Sales Growth YoY %Derived | — | 56.97% | 16.05% | 18.49% | 30.01% | 19.14% | |
| Other Income | 115 | 127 ▲ 11.0% | 139 ▲ 9.3% | 178 ▲ 27.9% | 156 ▼ 12.6% | 163 ▲ 4.5% | |
| Total Income | 2,619 | 4,059 ▲ 55.0% | 4,702 ▲ 15.8% | 5,584 ▲ 18.8% | 7,184 ▲ 28.7% | 8,536 ▲ 18.8% | |
594 | 923 ▲ 55.3% | 922 ▼ 0.1% | 1,119 ▲ 21.3% | 1,477 ▲ 32.1% | 1,790 ▲ 21.2% | ||
| Gross ProfitDerived | 1,910 | 3,009 ▲ 57.5% | 3,641 ▲ 21.0% | 4,288 ▲ 17.8% | 5,551 ▲ 29.5% | 6,583 ▲ 18.6% | |
| Gross Margin %Derived | 76.27% | 76.53% | 79.79% | 79.31% | 78.98% | 78.62% | |
1,506 | 2,066 ▲ 37.1% | 2,400 ▲ 16.2% | 2,795 ▲ 16.5% | 3,703 ▲ 32.5% | 4,341 ▲ 17.2% | ||
| EBITDA (Operating Profit)Derived | 404 | 943 ▲ 133.4% | 1,241 ▲ 31.6% | 1,492 ▲ 20.3% | 1,849 ▲ 23.9% | 2,243 ▲ 21.3% | |
| OPM %Derived | 16.12% | 23.97% | 27.19% | 27.60% | 26.30% | 26.79% | |
120 | 313 ▲ 161.1% | 316 ▲ 1.0% | 305 ▼ 3.5% | 451 ▲ 47.9% | 633 ▲ 40.5% | ||
| Profit Before Tax (PBT) | -69 | 739 ▲ 1176.3% | 1,064 ▲ 44.0% | 1,365 ▲ 28.4% | 1,406 ▲ 3.0% | 1,676 ▲ 19.1% | |
46 | 134 ▲ 191.9% | -40 ▼ 129.7% | 308 ▲ 873.3% | 330 ▲ 7.4% | 233 ▼ 29.4% | ||
| Effective Tax %Derived | -66.79% | 18.11% | -3.74% | 22.54% | 23.50% | 13.92% | |
| Total Profit for Period | -138 | 605 ▲ 539.9% | 1,104 ▲ 82.4% | 1,058 ▼ 4.2% | 1,076 ▲ 1.7% | 1,442 ▲ 34.1% | |
| Net Profit (Owner's PAT)Derived | -138 | 605 ▲ 539.9% | 1,104 ▲ 82.4% | 1,058 ▼ 4.2% | 1,076 ▲ 1.7% | 1,442 ▲ 34.1% | |
| Net Profit Margin %Derived | -5.49% | 15.39% | 24.19% | 19.56% | 15.31% | 17.23% | |
| PAT Growth YoY %Derived | — | 539.88% | 82.38% | -4.16% | 1.72% | 34.07% | |
| Earnings Per Share (EPS ₹) | -1.42 | 6.24 ▲ 539.4% | 11.37 ▲ 82.2% | 10.88 ▼ 4.3% | 11.07 ▲ 1.7% | 14.82 ▲ 33.9% | |
| Diluted Shares Outstanding (Cr) | 97 | 97 ▲ 0.4% | 97 ▲ 0.1% | 97 ▲ 0.1% | 97 ▲ 0.0% | 97 ▲ 0.1% | |
| Share of Profit from Associates/JVs | -23 | — ▲ 100.0% | — | — | — | — | |
| Other Comprehensive Income (Net of Tax) | 1 | 3 ▲ 419.6% | -0 ▼ 118.1% | -6 ▼ 1243.8% | -5 ▲ 29.5% | -2 ▲ 65.3% | |
| Total Expenses (incl. D&A & Interest) | 2,688 | 3,320 ▲ 23.5% | 3,638 ▲ 9.6% | 4,219 ▲ 16.0% | 5,778 ▲ 37.0% | 6,860 ▲ 18.7% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 23.51% | 19.33% | 17.74% | 17.28% | 16.70% | 16.21% | |
| Other Cost % of RevenueDerived | 36.64% | 33.22% | 34.86% | 34.42% | 35.98% | 35.63% | |
| Interest Coverage (x)Derived | 1.28x | 7.15x | 12.02x | 20.82x | 9.03x | 7.64x |
MAX HEALTHCARE INS segment analysis : revenue and profit mix.
Disclosed business segments at MAX HEALTHCARE INS with their share of revenue and profit, switchable between consolidated and standalone reporting.
MAX HEALTHCARE INS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for MAX HEALTHCARE INS.
Our AI distills the core fundamental drivers supporting MAX HEALTHCARE INS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
MAX HEALTHCARE INS's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 92 (~2.0× the sector multiple of 45.9) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.10%.
MAX HEALTHCARE INS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — MAX HEALTHCARE INS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
MAX HEALTHCARE INS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for MAX HEALTHCARE INS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
MAX HEALTHCARE INS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for MAX HEALTHCARE INS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in MAX HEALTHCARE INS stood at 64.9% of traded volume, against a 20-day average of 56.1%.
MAX HEALTHCARE INS announcements: results, concalls, ratings, M&A.
Filings MAX HEALTHCARE INS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
MAX HEALTHCARE INS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 200 documents below.
Shareholders meeting
Max Healthcare Institute Limited has informed the Exchange regarding Postal Ballot Notice.
General Updates
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure…
Analysts/Institutional Investor Meet/Con. Call Updates
Max Healthcare Institute Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Max Healthcare Institute Limited has informed the Exchange about Schedule of meet
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure…
Investor decks & rating reports.
MAX HEALTHCARE INS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue MAX HEALTHCARE INS has declared, sequenced by announce and record date.
MAX HEALTHCARE INS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About MAX HEALTHCARE INS: business, sector, key facts.
What MAX HEALTHCARE INS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
MAX HEALTHCARE INS operates in the Hospital industry under the Healthcare sector, listed as NSE: MAXHEALTH, BSE: 543220.
Max Healthcare Institute Limited is a major provider of medical and healthcare services in India, operating a diverse network of hospitals and medical centers across the country. Their services span a wide range of specialties, encompassing advanced cardiac care, orthopedics, oncology, renal sciences, neurosciences, and various surgical disciplines such as minimal access metabolic and bariatric surgery, obstetrics, gynecology, and general surgery. The company also offers highly specialized procedures such as liver, heart, kidney, lung, and bone marrow transplants, reflecting a commitment to comprehensive and advanced medical care.
Beyond its core hospital services, Max Healthcare boasts a significant presence in ancillary healthcare sectors. Max@Home provides a convenient alternative for patients seeking health and wellness services in the comfort of their own homes, expanding accessibility and convenience. Complementing this is MaxLab, a diagnostic services arm that extends its reach beyond the company's hospital network. MaxLab utilizes various channels including collaborations with third-party hospitals to provide diagnostic services to a broader patient base.
The company's business model is built around delivering high-quality healthcare across a spectrum of services and delivery methods. This integrated approach allows Max Healthcare to cater to a wide range of patient needs, from routine check-ups and diagnostics to complex surgical procedures and long-term care. The integration of hospital services, home healthcare, and diagnostic services creates a comprehensive ecosystem that enhances patient care and expands market reach. The company's incorporation in 2001 and continued operation in Gurugram, India demonstrates a long-standing commitment to serving the Indian healthcare market.
In summary, Max Healthcare Institute Limited’s business centers around providing a wide range of medical services, leveraging an integrated model of hospital care, home healthcare, and diagnostic testing. This multifaceted approach ensures accessibility and comprehensive care across a broad patient population within the Indian healthcare landscape, and positions them as a major player in the country's healthcare industry.
Go deeper on MAX HEALTHCARE INS
- MAX HEALTHCARE INS resultsQuarter-by-quarter revenue, profit, EPS and margins for MAX HEALTHCARE INS.
- MAX HEALTHCARE INS dividendEvery dividend MAX HEALTHCARE INS has declared, with ex-dates and yield.
- MAX HEALTHCARE INS shareholdingPromoter, FII and DII holding in MAX HEALTHCARE INS, quarter by quarter.
- MAX HEALTHCARE INS financialsMAX HEALTHCARE INS profit & loss, balance sheet and cash flow by year.
- MAX HEALTHCARE INS technical analysisPivots, CPR and live indicator readings for MAX HEALTHCARE INS.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- APOLLO HOSPITALS ENTER L (APOLLOHOSP) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- ASTER DM QUALITY CARE (ASTERDM) Share PricePeer
- FORTIS HEALTHCARE (FORTIS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about MAX HEALTHCARE INS (MAXHEALTH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of MAX HEALTHCARE INS (MAXHEALTH)?
The current share price of MAX HEALTHCARE INS (MAXHEALTH) is ₹1,049.30. Today, the stock has gained by ₹12.30 (1.19%), trading in a range of ₹1,034.90 to ₹1,059.90. The stock opened at ₹1,037.00 with a trading volume of 20,98,416 shares.
02Is MAX HEALTHCARE INS stock a good investment for long-term?
MAX HEALTHCARE INS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1.03 L Cr., P/E ratio of 70.43, ROE of 8.02%, and ROCE of 8.1%. The dividend yield stands at 0.19%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of MAX HEALTHCARE INS stock?
The 52-week high price of MAX HEALTHCARE INS (MAXHEALTH) is ₹1,221.90, while the 52-week low is ₹903.00. Currently trading at ₹1,049.30, the stock is 16.2% above its 52-week low and 14.13% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy MAX HEALTHCARE INS stock at the current price?
Whether to buy MAX HEALTHCARE INS stock at ₹1,049.30 depends on multiple factors. The stock is currently trading with a P/E ratio of 70.43 and P/B ratio of 9.55. Today's performance shows a gain of 1.19%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of MAX HEALTHCARE INS and when is the next dividend?
MAX HEALTHCARE INS offers a dividend yield of 0.19%, which means for every ₹100 invested at the current price of ₹1,049.30, you can expect to receive approximately ₹0.19 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of MAX HEALTHCARE INS?
MAX HEALTHCARE INS's key financial metrics include: P/E Ratio: 70.43, P/B Ratio: 9.55, ROE: 8.02%, ROCE: 8.1%, Dividend Yield: 0.19%, EPS: ₹3.32, Book Value: ₹110.42, and Debt-to-Equity: 0.09. The company's market cap stands at ₹1.03 L Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is MAX HEALTHCARE INS stock performing today in the market?
MAX HEALTHCARE INS stock opened at ₹1,037.00 and is currently trading at ₹1,049.30, showing a gain of ₹12.30 (1.19%). The intraday high is ₹1,059.90 and low is ₹1,034.90. The trading volume stands at 20,98,416 shares, indicating strong market participation today.
08What is the P/E ratio of MAX HEALTHCARE INS and what does it indicate?
MAX HEALTHCARE INS has a Price-to-Earnings (P/E) ratio of 70.43, which means investors are willing to pay 70.43 for every ₹1 of earnings. With an EPS of ₹3.32, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about MAX HEALTHCARE INS (MAXHEALTH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.